News Image

Global Cancer Vaccines Market Share Is Expected To Reach $19.27 Billion By 2030

Provided By PR Newswire

Last update: Oct 25, 2023

FinancialNewsMedia.com News Commentary  

PALM BEACH, Fla., Oct. 25, 2023 /PRNewswire/ -- The R&D for cancer vaccines has been growing in the last few years and is projected to continue through the next decade. A cancer vaccine is used to either prevent or cure a certain type of cancer. Vaccines used to treat already existing cancer are called tumor antigen vaccines or therapeutic cancer vaccines. Many vaccines that are already on the market or in the developed phase are autologous vaccines which means that they are created using samples from a patient and are to be used only for that patient. As studies have shown, certain cancers can develop due to cancerous cells which attack the immune system and tumors can generate if these cells are not destroyed. However, there are certain types of cancer that can start due to viruses like cervical cancer or liver cancer. These viruses are called oncoviruses. In such cases, cancer vaccines can be used to either prevent cancer or treat it. The first cancer case was over 3000 BC old and till 2022 there is not one cure that can guarantee the treatment of the disease and millions of people continue to die every year due to cancer. A report from Facts and Factors projected that the global cancer vaccines market size was worth around USD 6.45 billion in 2021 and is predicted to grow to around USD 19.27 billion by 2030 with a compound annual growth rate (CAGR) of roughly 14.75% between 2022 and 2030. Active Biotech Companies active today in markets include:  Defence Therapeutics Inc. (OTCPK: DTCFF) (CSE: DTC), Jazz Pharmaceuticals plc (NASDAQ: JAZZ), Exelixis, Inc. (NASDAQ: EXEL), Amgen (NASDAQ: AMGN), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN).

Read more at prnewswire.com

REGENERON PHARMACEUTICALS

NASDAQ:REGN (5/12/2025, 8:00:01 PM)

After market: 575.63 0 (0%)

575.63

+47.85 (+9.07%)


AMGEN INC

NASDAQ:AMGN (5/12/2025, 8:00:00 PM)

After market: 274.264 -0.5 (-0.18%)

274.76

+8.9 (+3.35%)


EXELIXIS INC

NASDAQ:EXEL (5/12/2025, 8:16:34 PM)

After market: 37.4981 +0.52 (+1.4%)

36.98

+0.81 (+2.24%)


JAZZ PHARMACEUTICALS PLC

NASDAQ:JAZZ (5/12/2025, 8:00:02 PM)

After market: 103.58 0 (0%)

103.58

+5.8 (+5.93%)



Find more stocks in the Stock Screener

REGN Latest News and Analysis

ChartMill News Image4 days ago - ChartmillLet's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.

Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Thursday. Stay informed about the market activity below.

Mentions: TAP NDAQ FTNT EPAM ...

ChartMill News Image4 days ago - ChartmillDiscover which S&P500 stocks are making waves on Thursday.

Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.

Mentions: OXY TAP LLY ALGN ...

ChartMill News Image4 days ago - ChartmillThursday's session: gap up and gap down stock in the S&P500 index

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.

Mentions: TAP AMGN LLY CAH ...

ChartMill News Image5 days ago - ChartmillThese S&P500 stocks that are showing activity before the opening bell on Thursday.

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

Mentions: TAP TPL WRB INCY ...

ChartMill News Image6 days ago - ChartmillWhat's going on in today's session: S&P500 movers

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.

Mentions: NEM F LLY MRK ...

ChartMill News Image6 days ago - ChartmillUncover the latest developments among S&P500 stocks in today's session.

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Mentions: APA WMB F ADM ...

ChartMill News Image12 days ago - ChartmillDespite its impressive fundamentals,REGENERON PHARMACEUTICALS (NASDAQ:REGN) remains undervalued.

REGENERON PHARMACEUTICALS has caught the attention as a great value stock. NASDAQ:REGN excels in profitability, solvency, and liquidity, all while being very reasonably priced.

ChartMill News Image12 days ago - ChartmillTop S&P500 movers in Wednesday's session

Stay updated with the movements of the S&P500 index one hour before the close of the markets on Wednesday. Discover which stocks are leading as top gainers and losers in today's session.

Mentions: PPG IP MLM VMC ...

ChartMill News Image12 days ago - ChartmillThese S&P500 stocks are moving in today's session

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Wednesday.

Mentions: PPG EXR MLM VMC ...

ChartMill News Image13 days ago - ChartmillDiscover which S&P500 stocks are making waves on Tuesday.

Let's delve into the developments on the US markets one hour before the close of the markets on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Mentions: SHW NEM APA AJG ...

ChartMill News Image13 days ago - ChartmillExploring the top movers within the S&P500 index during today's session.

Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.

Mentions: SHW PCAR BRO CINF ...

ChartMill News Image13 days ago - ChartmillWhich S&P500 stocks are gapping on Tuesday?

Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index.

Mentions: PCAR BRO ARE BXP ...

Follow ChartMill for more